Solian Amisulpride Tablet
Solian (Amisulpride) Tablet Benzamide Antipsychotic for Schizophrenia & Negative Symptoms Narix Pharmaceuticals
Narix Pharmaceuticals manufactures Amisulpride Tablets, a substituted benzamide with dose-dependent effects � low doses improve negative symptoms (presynaptic D2 block), high doses treat positive symptoms (postsynaptic D2 block).
Key Therapeutic Uses:
� Schizophrenia � positive and negative symptoms
� Negative symptom-predominant schizophrenia
� Dysthymia/persistent depressive disorder (low dose)
� Postoperative nausea and vomiting (off-label)
Available Strengths: 50 mg 100 mg 200 mg 400 mg
Product Highlights:
� Dose-dependent dual mechanism � unique pharmacology
� Effective for negative symptoms
� WHO-GMP, DCGI approved
� PCD pharma franchise & bulk export
Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M
#AmisulprideTablet #SolianGeneric #BenzamideAntipsychotic #NegativeSymptomSchizophrenia #SchizophreniaTablet #AmisulprideManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine